Uplift (Engot-OV67/Gog-3048): A Pivotal Cohort of Upifitamab Rilsodotin (XMT-1536; UpRi), an Napi2B-Directed Dolaflexin Antibody Drug Conjugate (ADC) In Platinum-Resistant Ovarian Cancer